AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22015574 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 19897461 — intervention group
Group type: EXPERIMENTAL
Intervention: External counterpulsation (ECP)
Number of subjects: 20
Study 19897461 — intervention group
Group type: COMPARATOR
Intervention: Sham ECP
Number of subjects: 20
Study 18058723 — intervention group
Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet (45% of energy from carbohydrates)
Number of subjects: 30
Study 18058723 — intervention group
Group type: EXPERIMENTAL
Intervention: High carbohydrate diet (65% of energy from carbohydrates)
Number of subjects: 30
Study 18058723 — intervention group
Group type: EXPERIMENTAL
Intervention: Both diets
Number of subjects: 30
Study 16284385 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli sprouts infusion containing 400 micromol glucoraphanin
Number of subjects: 200
Study 16284385 — intervention group
Group type: EXPERIMENTAL
Intervention: Broccoli sprouts infusion containing < 3 micromol glucoraphanin
Number of subjects: 200
Study 16284385 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 200
Study 12383039 — intervention group
Group type: EXPERIMENTAL
Intervention: Fondaparinux sodium 2.5mg subcutaneously
Number of subjects: 8
Study 9159442 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular induction and exposure to laboratory conditions
Number of subjects: 4
Study 9159442 — intervention group
Group type: COMPARATOR
Intervention: Embryos obtained before 1991
Number of subjects: 4
Study 8131453 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic training at ventilatory threshold (Vth) intensity level for three months, three times per week.
Number of subjects: 48
Study 8131453 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training).
Number of subjects: 48
Study 8131453 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-MST (20-meter shuttle test) as an indirect measure.
Number of subjects: 48
Study 3113823 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG‐IUD (n = 14 women)
Number of subjects: 38
Study 3113823 — intervention group
Group type: EXPERIMENTAL
Intervention: Norplant (R)‐2 (n = 14 women)
Number of subjects: 38
Study 3113823 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG minipills (n = 10 women)
Number of subjects: 38
Study 31464548 — intervention group
Group type: EXPERIMENTAL
Intervention: Single SUI treatment (Group 1)
Number of subjects: 0
Study 31464548 — intervention group
Group type: EXPERIMENTAL
Intervention: Two SUI treatments (Group 2)
Number of subjects: 0
Study 31464548 — intervention group
Group type: EXPERIMENTAL
Intervention: CMRF Viveve System
Number of subjects: 0
Study 29884488 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower leg saphenous vein composite graft
Number of subjects: 26
Study 29884488 — intervention group
Group type: COMPARATOR
Intervention: Upper leg saphenous vein composite graft
Number of subjects: 26
Study 27562731 — intervention group
Group type: EXPERIMENTAL
Intervention: One-night total sleep deprivation (TSD)
Number of subjects: 16
Study 27562731 — intervention group
Group type: COMPARATOR
Intervention: One-night normal sleep (NS)
Number of subjects: 16
Study 24943129 — intervention group
Group type: EXPERIMENTAL
Intervention: Daptomycin
Number of subjects: 50
Study 24943129 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 50
Study 23210360 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcurrent reflexotherapy (MCRT) combined with cortexin therapy, massage, and remedial gymnastics
Number of subjects: 69
Study 23210360 — intervention group
Group type: COMPARATOR
Intervention: Massage and remedial gymnastics alone (Control)
Number of subjects: 69
Study 21197917 — intervention group
Group type: EXPERIMENTAL
Intervention: Videophone motivational interviewing diabetes self-management education (DSME) intervention
Number of subjects: 66
Study 21197917 — intervention group
Group type: COMPARATOR
Intervention: Monthly videophone healthy-lifestyle education calls (Control)
Number of subjects: 66
Study 18491100 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-source CT (DSCT)
Number of subjects: 12
Study 17081398 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated fibrinogen (fibrinogen level > 4.0 g/L, n = 81)
Number of subjects: 185
Study 17081398 — intervention group
Group type: COMPARATOR
Intervention: Control fibrinogen (fibrinogen level < or = 4.0 g/L, n = 104)
Number of subjects: 185
Study 17081398 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated hs-CRP (hs-CRP > 3.0 mg/L, n = 86)
Number of subjects: 185
Study 17081398 — intervention group
Group type: COMPARATOR
Intervention: Control hs-CRP (hs-CRP < or = 3.0 mg/L, n = 99)
Number of subjects: 185
Study 17081398 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of elevated fibrinogen and hs-CRP
Number of subjects: 185
Study 12681023 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (RSG) added to 2.5 g/day of metformin (MET)
Number of subjects: 550
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 16 mg/day
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 32 mg/day
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (pooled data from two 6-month studies, n = 1,269)
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (for moderately severe disease)
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine 24 mg/day (12-month study)
Number of subjects: 3000
Study 10971048 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (5-month placebo-controlled study)
Number of subjects: 3000
Study 10971048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3000
Study 8997651 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% hexetidine spray
Number of subjects: 38
Study 8997651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 1546121 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide (150 mg, increased to 450 mg if necessary)
Number of subjects: 126
Study 1546121 — intervention group
Group type: COMPARATOR
Intervention: Fluvoxamine (50 mg, increased to 200 mg if necessary)
Number of subjects: 126
Study 3979278 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible rectoscope
Number of subjects: 114
Study 3979278 — intervention group
Group type: COMPARATOR
Intervention: Rigid rectoscope
Number of subjects: 114
Study 31917233 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgical targeted antibiotic therapy for 2 weeks
Number of subjects: 0
Study 29328007 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydration (0.9% NaCl)
Number of subjects: 660
Study 29328007 — intervention group
Group type: COMPARATOR
Intervention: No prophylaxis
Number of subjects: 660
Study 26677057 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact casein infusion
Number of subjects: 13
Study 26677057 — intervention group
Group type: EXPERIMENTAL
Intervention: Casein hydrolysate infusion
Number of subjects: 13
Study 24841647 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrophilic resorbable film PREVADH™ applied directly to the incisions (P-Group)
Number of subjects: 61
Study 24841647 — intervention group
Group type: COMPARATOR
Intervention: Ringer's lactate solution instilled into the pelvic cavity (R-Group)
Number of subjects: 61
Study 22643446 — intervention group
Group type: EXPERIMENTAL
Intervention: BI300, TiOblast‐coated fixture
Number of subjects: 10
Study 22643446 — intervention group
Group type: COMPARATOR
Intervention: Previous generation, pure titanium fixture (control group)
Number of subjects: 10
Study 20178647 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitoxantrone, estramustine and vinorelbine (MEV)
Number of subjects: 70
Study 20178647 — intervention group
Group type: COMPARATOR
Intervention: 13-cis retinoic acid (CRA), interferon-alpha2b (IFN) and paclitaxel (TAX)
Number of subjects: 70
Study 19087330 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidisciplinary group treatment (Go4it)
Number of subjects: 0
Study 19087330 — intervention group
Group type: COMPARATOR
Intervention: Usual care (referral to a dietician)
Number of subjects: 0
Study 16160575 — intervention group
Group type: EXPERIMENTAL
Intervention: Frialit‐2 implants or IMZ Twin Plus implants
Number of subjects: 93
Study 16160575 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco consumption
Number of subjects: 93
Study 16160575 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-tooth replacement or removable prosthesis
Number of subjects: 93
Study 16160575 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum osteocalcin, urinary pyridinoline, and deoxypyridinoline
Number of subjects: 93
Study 11991771 — intervention group
Group type: EXPERIMENTAL
Intervention: MAX‐ECC
Number of subjects: 8
Study 11991771 — intervention group
Group type: COMPARATOR
Intervention: 50%‐ECC
Number of subjects: 8
Study 11329114 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium citrate (800 mg daily)
Number of subjects: 63
Study 11329114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 7548480 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 30
Study 7548480 — intervention group
Group type: COMPARATOR
Intervention: Enflurane
Number of subjects: 30
Study 2405642 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 micrograms arbaprostil qid for 4 weeks
Number of subjects: 630
Study 2405642 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 micrograms arbaprostil qid for 4 weeks
Number of subjects: 630
Study 2405642 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 630
Study 347110 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluphenazine hydrochloride
Number of subjects: 30
Study 347110 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine hydrochloride
Number of subjects: 30
Study 31612630 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic exercise with blood flow restriction (BFR)
Number of subjects: 22
Study 31612630 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise alone
Number of subjects: 22
Study 30074678 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimistic imagery condition
Number of subjects: 45
Study 30074678 — intervention group
Group type: COMPARATOR
Intervention: Neutral imagery condition
Number of subjects: 45
Study 30074678 — intervention group
Group type: EXPERIMENTAL
Intervention: Dispositional optimism
Number of subjects: 45
Study 30074678 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain catastrophizing and pain expectations
Number of subjects: 45
Study 27629597 — intervention group
Group type: EXPERIMENTAL
Intervention: Incredible Years (IY) parent program
Number of subjects: 341
Study 26054119 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlortetracycline treatment
Number of subjects: 194
Study 26054119 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlortetracycline + beclomethasone treatment
Number of subjects: 194
Study 26054119 — intervention group
Group type: COMPARATOR
Intervention: Beclomethasone treatment
Number of subjects: 194
Study 23140198 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow examinations in ITP patients
Number of subjects: 32
Study 23140198 — intervention group
Group type: COMPARATOR
Intervention: Bone marrow examinations in controls
Number of subjects: 32
Study 20546573 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (CPAP = 40 cm H2O for 40 s) in hypervolemic group
Number of subjects: 66
Study 20546573 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment Maneuver (CPAP = 40 cm H2O for 40 s) in hypovolemic and normovolemic groups
Number of subjects: 66
Study 20546573 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypervolemia (MAP approximately 130 mmHg)
Number of subjects: 66
Study 20546573 — intervention group
Group type: COMPARATOR
Intervention: Normovolemia (MAP approximately 100 mmHg)
Number of subjects: 66
Study 20546573 — intervention group
Group type: COMPARATOR
Intervention: Hypovolemia (MAP approximately 70 mmHg)
Number of subjects: 66
Study 18249128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bypass surgery
Number of subjects: 825
Study 18249128 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-vessel disease (3VD)
Number of subjects: 825
Study 16052254 — intervention group
Group type: EXPERIMENTAL
Intervention: Pars plana vitrectomy (PPV)
Number of subjects: 20
Study 16052254 — intervention group
Group type: COMPARATOR
Intervention: Standard macular photocoagulation
Number of subjects: 20
Study 12804055 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimatoprost 0.03% once daily
Number of subjects: 32
Study 11040246 — intervention group
Group type: EXPERIMENTAL
Intervention: Lacidipine (4 mg once daily for 4 weeks)
Number of subjects: 10
Study 8897117 — intervention group
Group type: EXPERIMENTAL
Intervention: IBM care measures
Number of subjects: 105
Study 8897117 — intervention group
Group type: EXPERIMENTAL
Intervention: IBM care measures (restricted sample)
Number of subjects: 105
Study 1801333 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral chloroquine (nasogastric tube)
Number of subjects: 113
Study 1801333 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular chloroquine (3.5 mg/kg 8-hourly)
Number of subjects: 113
Study 1801333 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 113
Study 6591740 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol (300 mg I/ml)
Number of subjects: 51
Study 6591740 — intervention group
Group type: COMPARATOR
Intervention: Diatrizoate (290 mg I/ml)
Number of subjects: 51
Study 6591740 — intervention group
Group type: EXPERIMENTAL
Intervention: Iohexol
Number of subjects: 51
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets by overweight females
Number of subjects: 316
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets by healthy females
Number of subjects: 316
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets by healthy weight users
Number of subjects: 316
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Tweets by overweight users
Number of subjects: 316
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Male participants
Number of subjects: 316
Study 29388884 — intervention group
Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 316
Study 27392025 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol warning advertisements
Number of subjects: 152
Study 27392025 — intervention group
Group type: COMPARATOR
Intervention: Alcohol promoting advertisements
Number of subjects: 152
Study 27392025 — intervention group
Group type: COMPARATOR
Intervention: Non-alcohol advertisements
Number of subjects: 152
Study 24681813 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone technology intervention for health information exposure
Number of subjects: 0
Study 24681813 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple treatment framework with different variants emphasizing monetary and non-monetary benefits and costs
Number of subjects: 0
Study 23610561 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate infusion (5.1 mmol/kg for 24 hours)
Number of subjects: 350
Study 23610561 — intervention group
Group type: COMPARATOR
Intervention: Sodium chloride infusion (5.1 mmol/kg for 24 hours)
Number of subjects: 350
Study 21480703 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples' group meeting for 16 weeks focusing on couple relationship issues
Number of subjects: 100
Study 21480703 — intervention group
Group type: EXPERIMENTAL
Intervention: Couples' group meeting for 16 weeks focusing on parenting issues
Number of subjects: 100
Study 21480703 — intervention group
Group type: COMPARATOR
Intervention: Low-dose control condition
Number of subjects: 100
Study 18314072 — intervention group
Group type: EXPERIMENTAL
Intervention: Welch-Allyn SureSight autorefractor
Number of subjects: 100
Study 18314072 — intervention group
Group type: EXPERIMENTAL
Intervention: MTI photoscreener
Number of subjects: 100
Study 16984383 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral bovine lactoferrin (bLF) at a dose of 1.8 g daily for 12 weeks
Number of subjects: 199
Study 16984383 — intervention group
Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 199
Study 14616447 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced prostate cancer patients (174 patients)
Number of subjects: 174
Study 14616447 — intervention group
Group type: COMPARATOR
Intervention: Age-matched control group (106 controls)
Number of subjects: 174
Study 11074684 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care with manual therapy
Number of subjects: 295
Study 11074684 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care with manual therapy (four or more maneuvers)
Number of subjects: 295
Study 11074684 — intervention group
Group type: COMPARATOR
Intervention: Enhanced care alone
Number of subjects: 295
Study 8997555 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin 500 mg once daily for three days
Number of subjects: 438
Study 1638586 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 200 mg daily for three days
Number of subjects: 202
Study 1638586 — intervention group
Group type: COMPARATOR
Intervention: TMP/SMX 160 mg/800 mg twice daily for seven days
Number of subjects: 202
Study 6703672 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalcillin (2-g dose, intravenous)
Number of subjects: 10
Study 6703672 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin (2-g dose, intravenous)
Number of subjects: 10
Study 6703672 — intervention group
Group type: EXPERIMENTAL
Intervention: Apalcillin
Number of subjects: 10
Study 6703672 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin
Number of subjects: 10
Study 31406349 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual azithromycin distribution
Number of subjects: 30
Study 31406349 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29365187 — intervention group
Group type: EXPERIMENTAL
Intervention: Supportive clinical practice change strategies
Number of subjects: 4
Study 29365187 — intervention group
Group type: COMPARATOR
Intervention: Preintervention period
Number of subjects: 4
Study 29365187 — intervention group
Group type: EXPERIMENTAL
Intervention: Postintervention period
Number of subjects: 4
Study 26561996 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma of argon treatment
Number of subjects: 30
Study 26561996 — intervention group
Group type: COMPARATOR
Intervention: Cleaning protocol by steaming (Control)
Number of subjects: 30
Study 24299662 — intervention group
Group type: EXPERIMENTAL
Intervention: EGCG (300 mg/d)
Number of subjects: 83
Study 22453114 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-domain cognitive training (CogTr)
Number of subjects: 270
Study 22453114 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-domain cognitive training (CogTr)
Number of subjects: 270
Study 22453114 — intervention group
Group type: EXPERIMENTAL
Intervention: Booster training sessions (offered to 60% of initial training participants)
Number of subjects: 270
Study 22453114 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 270
Study 20604801 — intervention group
Group type: EXPERIMENTAL
Intervention: Bet v 1 trimer (n=14)
Number of subjects: 46
Study 20604801 — intervention group
Group type: EXPERIMENTAL
Intervention: Bet v 1 fragments (n=11)
Number of subjects: 46
Study 20604801 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=21)
Number of subjects: 46
Study 17494794 — intervention group
Group type: EXPERIMENTAL
Intervention: Moli1901 (2.5 mg/d)
Number of subjects: 24
Study 16645534 — intervention group
Group type: COMPARATOR
Intervention: Methyltestosterone (2.5 mg)
Number of subjects: 72
Study 16645534 — intervention group
Group type: COMPARATOR
Intervention: Estrogen + medroxyprogesterone + methyltestosterone
Number of subjects: 72
Study 16645534 — intervention group
Group type: COMPARATOR
Intervention: Methyltestosterone only
Number of subjects: 72
Study 16645534 — intervention group
Group type: COMPARATOR
Intervention: No hormone therapy (placebo)
Number of subjects: 72
Study 12643006 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized sucralfate mouthwash
Number of subjects: 30
Study 12643006 — intervention group
Group type: COMPARATOR
Intervention: Salt & soda mouthwash
Number of subjects: 30
Study 10606936 — intervention group
Group type: EXPERIMENTAL
Intervention: FPND 400 microg twice daily (b.i.d.)
Number of subjects: 142
Study 10606936 — intervention group
Group type: EXPERIMENTAL
Intervention: FPND 400 microg once daily (o.d.)
Number of subjects: 142
Study 10606936 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 10606936 — intervention group
Group type: EXPERIMENTAL
Intervention: FPND 400 microg once daily (o.d.) and FPND 400 microg twice daily (b.i.d.)
Number of subjects: 142
Study 8891846 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosulpiride (25 mg tid)
Number of subjects: 1298
Study 8891846 — intervention group
Group type: COMPARATOR
Intervention: Domperidone (10 mg tid)
Number of subjects: 1298
Study 8891846 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide (10 mg tid)
Number of subjects: 1298
Study 8891846 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1 tablet tid)
Number of subjects: 1298
Study 1873267 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel method of eyedrop instillation (applied to the inner canthus with eyes tightly closed and subject supine)
Number of subjects: 0
Study 1873267 — intervention group
Group type: COMPARATOR
Intervention: Conventional instillation (into the conjunctival sac, with or without 2 min pressure on the inner canthus)
Number of subjects: 0
Study 6359724 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 50 mg
Number of subjects: 0
Study 6359724 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (50-500 mg)
Number of subjects: 0
Study 30428707 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting First Relationships® (PFR) intervention
Number of subjects: 247
Study 30428707 — intervention group
Group type: COMPARATOR
Intervention: Control intervention
Number of subjects: 247
Study 29189447 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer evaluation technique during clinical skill practice sessions
Number of subjects: 0
Study 29189447 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0